Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary Prevention (PANDORA)

AstraZeneca

Status: Completed

Conditions: Peripheral Arterial Disease (PAD); Moderate Risk for Cardiovascular Disease (CVD)

Study type: Observational

Funder types: Industry

Identifiers

NCT00689377

NIS-CEU-DUM-2006/1

Details and patient eligibility

About

Non interventional study aimed to establish the prevalence of lower extremity peripheral arterial disease (PAD), defined as an ankle-brachial index (ABI) not above 0.90 in subjects with a moderate risk of cardiovascular disease, with no overt cardiovascular diseases nor diabetes mellitus.

Enrollment: 9,000 patients

Sex: All

Ages: 45+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male subject aged 45 years or above, or female subject aged 55 years or above (age-related CVD risk factor)
• At least another of the following risk factor for CVD: cigarette smoking, hypertension, low HDL cholesterol or high LDL cholesterol, family history of premature coronary heart disease, elevated waist circumference
• Willingness to participate in the survey and complying with the study by signing a written informed consent

Exclusion criteria

• No or 1 risk factor for CVD; symptoms of PAD; diabetes mellitus; coronary heart disease or equivalents
• No lipid data collected in the last 12 months
• Serious or unstable medical or psychological conditions that, in the opinion of the Investigator, would compromise the subject's safety or successful participation in the study; unwilling or unable to provide informed consent

Trial design

9,000 participants in 1 patient group

1

Description:

Subjects of either sex, any race, with at least two CVD risk factors, with no overt cardiovascular diseases nor diabetes mellitus